Search for European Projects

5 European Projects Found

Searched on 125080 European Projects

 FINISHED 

"Training in neurodegeneration, therapeutics intervention and neurorepair" (TINTIN)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

"Dopamine neurons play a central role in major illnesses, such as anxiety and mood disorders, schizophrenia, autism-spectrum disorders, Parkinson’s disease, epilepsy, and dementia. A multidisciplinary approach must be taken by European researchers to discover the molecular basis of dopamine neurodegeneration and how new technologies will lead to repair and regeneration of neuronal systems in the b ...
Read Project

 8

 FINISHED 

Methods for high-throughput (HTP) analysis of protein glycosylation (HighGlycan)

Start date: Nov 1, 2011, End date: Oct 31, 2016,

Glycosylation is a post-translational modification that enriches protein complexity and function. Dysregulation of glycosylation is associated with a wide range of diseases, including cancer, diabetes, as well as congenital, cardiovascular, immunological and infectious disorders. A number of studies identified potentially important glycan disease biomarkers. With regard to biotechnology, proper gl ...
Read Project

 9

 FINISHED 

Tools for the Detection of Novel Glyco-biomarkers (GlycoBioM)

Start date: Jan 1, 2011, End date: Dec 31, 2015,

Glycosylation patterns on glycoproteins and glycolipids are involved in the regulation of inter- and intracellular recognition events and alteration of such glycosylation has been observed in many diseases, notably in a variety of cancers. We propose that a systematic, large scale investigation in this area will provide a rich spectrum of novel and structurally diverse carbohydrate-based highly sp ...
Read Project

 6

 FINISHED 

Glycomics by High-throughput Integrated Technologies (GlycoHIT)

Start date: Jan 1, 2011, End date: Jun 30, 2014,

Protein glycosylation is a post-translational phenomenon that is involved in most physiological and disease processes including cancer. Most of the known cancer-associated glycobiomarkers were discovered individually using liquid chromatography and mass spectroscopy. Though valuable, there is room for improvement in these approaches for the discovery phase. There is also a critical need for innova ...
Read Project

 16

 FINISHED 

Developing minimally invasive, tools and technologies for high throughput, low cost molecular assays for the early diagnosis of schizophrenia and other psychiatric disorders (SchizDX)

Start date: Oct 1, 2008, End date: Mar 31, 2012,

Schizophrenia and bipolar affective disorder are a major burden to affected individuals and their families and to society at large. These two severe mental illnesses affect at least 2% of the population worldwide, and whilst 50% of sufferers do not receive adequate treatment, they cost hundreds of billions in healthcare provision, treatments and lost earnings. The current diagnosis of schizophreni ...
Read Project

 9